Most concerns resolve with small adjustments to fitness level or food timing
This article is not offering medical advice
Since no GLP-1 patches are currently FDA-approved , there is no established wear schedule for such products
Diabetes Diabetics should be aware that Saxenda will likely lower their blood sugars, and adjustments in diabetes medications may be necessary
Hims & Hers said its oral semaglutide "empowers providers to tailor treatment plans specifically for those who prefer to avoid needles or need smaller doses to help to balance side-effects." It added that its compounding operations "adhere to all federal and state standards for compounding, and all active pharmaceutical ingredientsin compounded treatments are sourced exclusively from FDA-registered facilities." In its statement, Novo Nordisk said the American Diabetes Association's Obesity Association recently published new standards of care, which "discourage the use of compounded GLP-1s due to safety, quality, and effectiveness concerns." Meanwhile, FDA Commissioner Marty Makary delivered some encouraging news to Novo Nordisk, after pledging "swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products."
When a GLP-1 medication reduces appetite, it does so partly by modulating dopamine signaling in the brains reward system
